115 related articles for article (PubMed ID: 30449892)
21. Evaluation of the "Dip Effect" Phenomenon in Antifungal Susceptibility Testing of Candida spp. against Echinocandins by Use of Gradient Concentration Strips.
Siopi M; Tsala M; Siafakas N; Zerva L; Meletiadis J
J Clin Microbiol; 2015 Nov; 53(11):3654-9. PubMed ID: 26338855
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of antifungal combinations against Candida albicans biofilms.
Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E
J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142
[TBL] [Abstract][Full Text] [Related]
23. Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals.
Choi HW; Shin JH; Jung SI; Park KH; Cho D; Kee SJ; Shin MG; Suh SP; Ryang DW
Antimicrob Agents Chemother; 2007 Apr; 51(4):1520-3. PubMed ID: 17283191
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the Sensititre Yeast One microdilution method for susceptibility testing of Candida species to anidulafungin, caspofungin, and micafungin.
García-Agudo L; García-Martos P; Martos-Cañadas J; Aznar-Marín P; Marín-Casanova P; Rodríguez-Iglesias M
Rev Esp Quimioter; 2012 Dec; 25(4):256-60. PubMed ID: 23303256
[TBL] [Abstract][Full Text] [Related]
25. Identification of the paradoxical effect of caspofungin and micafungin on
Zhouying H; Chen L; Ruiqi W; Kang L; Ji Z
Indian J Med Microbiol; 2017; 35(2):252-255. PubMed ID: 28681815
[TBL] [Abstract][Full Text] [Related]
26. Proanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment.
de Freitas ALD; Kaplum V; Rossi DCP; da Silva LBR; Melhem MSC; Taborda CP; de Mello JCP; Nakamura CV; Ishida K
J Ethnopharmacol; 2018 Apr; 216():184-190. PubMed ID: 29325916
[TBL] [Abstract][Full Text] [Related]
27. Use of fluorescent probes to determine MICs of amphotericin B and caspofungin against Candida spp. and Aspergillus spp.
Peter J; Armstrong D; Lyman CA; Walsh TJ
J Clin Microbiol; 2005 Aug; 43(8):3788-92. PubMed ID: 16081911
[TBL] [Abstract][Full Text] [Related]
28. Caspofungin-induced in-vitro post-antifungal effect and its impact on adhesion related traits of oral Candida dubliniensis and Candida albicans isolates.
Ellepola AN; Chandy R; Khan ZU; Samaranayake LP
Microbiol Immunol; 2016 Mar; 60(3):160-7. PubMed ID: 26850765
[TBL] [Abstract][Full Text] [Related]
29. Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms.
Delattin N; De Brucker K; Vandamme K; Meert E; Marchand A; Chaltin P; Cammue BP; Thevissen K
J Antimicrob Chemother; 2014 Apr; 69(4):1035-44. PubMed ID: 24284780
[TBL] [Abstract][Full Text] [Related]
30. Caspofungin-non-susceptible Candida isolates in cancer patients.
Kofteridis DP; Lewis RE; Kontoyiannis DP
J Antimicrob Chemother; 2010 Feb; 65(2):293-5. PubMed ID: 20016020
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of Caspofungin combined with Fluconazole on mixed Candida albicans and Candida glabrata biofilm.
Pesee S; Angkananuwat C; Tancharoensukjit S; Muanmai S; Sirivan P; Bubphawas M; Tanarerkchai N
Med Mycol; 2016 May; 54(4):384-93. PubMed ID: 26768371
[TBL] [Abstract][Full Text] [Related]
32. Comparative in vitro susceptibility of clinical isolates of Candida paparsilosis complex and other Candida species to caspofungin and anidulafungin by Etest.
Khan Z; Ahmad S; Joseph L; Chandy R; Theyyathel A
J Chemother; 2011 Apr; 23(2):97-101. PubMed ID: 21571626
[TBL] [Abstract][Full Text] [Related]
33. The patterns of colonization and antifungal susceptibility of Candida, isolated from preterm neonates in Khorramabad, South West of Iran.
Kooshki P; Rezaei-Matehkolaei A; Mahmoudabadi AZ
J Mycol Med; 2018 Jun; 28(2):340-344. PubMed ID: 29530715
[TBL] [Abstract][Full Text] [Related]
34. Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.
Marcos-Zambrano LJ; Gómez-Perosanz M; Escribano P; Zaragoza O; Bouza E; Guinea J
Antimicrob Agents Chemother; 2016 Jun; 60(6):3579-86. PubMed ID: 27021323
[TBL] [Abstract][Full Text] [Related]
35. Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates.
Pfaller MA; Messer SA; Rhomberg PR; Jones RN; Castanheira M
J Antimicrob Chemother; 2016 Oct; 71(10):2868-73. PubMed ID: 27287236
[TBL] [Abstract][Full Text] [Related]
36. In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital.
Arikan S; Sancak B; Hascelik G
Med Mycol; 2005 Mar; 43(2):171-8. PubMed ID: 15832560
[TBL] [Abstract][Full Text] [Related]
37. Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin-specific and candida species-related differences.
Chamilos G; Lewis RE; Albert N; Kontoyiannis DP
Antimicrob Agents Chemother; 2007 Jun; 51(6):2257-9. PubMed ID: 17438060
[TBL] [Abstract][Full Text] [Related]
38. Effect of nikkomycin Z and 50% human serum on the killing activity of high-concentration caspofungin against Candida species using time-kill methodology.
Szilágyi J; Földi R; Bayegan S; Kardos G; Majoros L
J Chemother; 2012 Feb; 24(1):18-25. PubMed ID: 22546720
[TBL] [Abstract][Full Text] [Related]
39. The postantifungal and paradoxical effects of echinocandins against Candida spp.
Moriyama B; Henning SA; Penzak SR; Walsh TJ
Future Microbiol; 2012 May; 7(5):565-9. PubMed ID: 22568712
[TBL] [Abstract][Full Text] [Related]
40. Changes in cell wall synthesis and ultrastructure during paradoxical growth effect of caspofungin on four different Candida species.
Bizerra FC; Melo AS; Katchburian E; Freymüller E; Straus AH; Takahashi HK; Colombo AL
Antimicrob Agents Chemother; 2011 Jan; 55(1):302-10. PubMed ID: 21060107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
